Orange County NC Website
Section 6 -Evaluation <br />ORHCC will submit the following reports quarterly (items 1, 2, 3 below) and annually (item 4 below) to the <br />Office of the Secretary. <br />1. Potentially Preventable Readmissions within 30 days as a Percent of Total Hospital Admissions, <br />aniong enrolled non-duals, any diagnosis <br />• Same-day transfers, long terns care admissions, rehabilitation, state mental hospital, hospice <br />admissions, and observation stays are not considered hospital admissions <br />• Admissions are excluded from both the numerator and denominator if either the initial or <br />readmission DRGs indicates: malignancy, trauma, obstetrical. burn, or newborn. All other <br />admissions are included. <br />Target: <br />• 5% reduction from network's baseline rate (SFY 08) by end of year 1 (SFY 10) <br />• ] 0% reduction from baseline rate by end of year 2 (SFY 11) <br />• I S% reduction from baseline rate by end of year 3 (SFY 12) <br />2. ED rate, enrolled ABD (dual +nondual) <br />Target: <br />• 5% reduction from network's baseline rate (SFY 08) by end of year 1 (SFY 10) <br />• 10% reduction from baseline rate by end of year 2 (SFY 11) <br />• 15% reduction from baseline rate by end of year 3 (SFY 12) <br />3. Generic Medications as Percent of All Fills, all Medicaid non-duals <br />Target: <br />• 2.5 percentage point increase from network's base]ine rate (SFY O8) by end of year ] (SFY <br />10), or 80%. whichever is lower <br />• 5 percentage point increase from baseline rate by end of year 2 (SFY 11), or 80%. whichever <br />is lower <br />• 7.5 percentage point increase from baseline rate by end of year 3 (SFY 12). or 80%, <br />whichever is lower <br />4. Quality of Care Measures, enrolled dual + non-dual <br />• per QMAF methodology (chart review measures only). pertaining to: asthma, diabetes. <br />hypertension. heart failure, ischemic vascular disease <br />Target: <br />• Improvement over network baseline (CY 2009) demonstrated in 50% of chart review <br />measures in CY 2010 and 75% of chart review measures in CY 20] 1 <br />17 <br />